Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Dermatology and Therapy|May 3, 2026
Rapid Onset of Action and Quality-of-Life Improvements in Chinese Patients with Plaque Psoriasis Treated with Calcipotriol plus Betamethasone Dipropionate Aerosol Foam in a Randomized Phase 3 TrialLin Cai, Furen Zhang, Guoqiang Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 20, 2025
Rapid Arbitrary-Shape Microscopy of Unsectioned Tissues for Precise Intraoperative Tumor Margin AssessmentZhicheng Shao, Xiangwei Meng, Peifen Fu, et al.
Dermatology and Therapy|February 11, 2026
Real-World Characteristics, Treatment Patterns, and Outcomes in Adult Patients Receiving Abrocitinib for Atopic Dermatitis in China: Interim Analysis from the AHEAD RegistryLi Zhang, Naihui Zhou, Zhouwei Wu, et al.
Allergy|October 25, 2024
Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trialYan Zhao, Litao Zhang, Liming Wu, et al.
Advances in Therapy|January 27, 2026
Efficacy and Safety of Switching to Picankibart from Non-interleukin-23 Subunit p19 Inhibitors in Patients with Plaque Psoriasis: A Multicenter, Open-Label, Phase 2 TrialQing Yang, Bin Yang, Heng Gu, et al.
Chinese Medical Journal|July 23, 2023
Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trialYan Zhao, Jianzhong Zhang, Bin Yang, et al.
Advances in Therapy|July 12, 2025
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 TrialYan Zhao, Litao Zhang, Liming Wu, et al.
Clinical and Translational Allergy|November 19, 2025
Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3 TrialYan Zhao, Litao Zhang, Liming Wu, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 28, 2025
Long-Term Stapokibart Treatment Induces Sustained Clinical Improvements in Patients With Moderate-to-Severe Atopic DermatitisYan Zhao, Litao Zhang, Liming Wu, et al.
International Journal of Dermatology|November 22, 2025
Efficacy and Safety of Anti-IL-4Rα Stapokibart in Elderly Patients With Moderate-To-Severe Atopic DermatitisYan Zhao, Litao Zhang, Liming Wu, et al.
Pageof 3